Genomadix Bioscience receives Health Canada approval for first near-patient DNA test for personalized medicine.

01/24/2018

Genomadix Bioscience today announced that Health Canada has approved the Genomadix RX CYP2C19 System. It is the first near-patient DNA test for personalized medicine that has been approved in Canada.

PRWeb

Discover More Articles

Which Test Are You Looking For?